Mount Yale Investment Advisors, LLC Biogen Inc. Transaction History

Mount Yale Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $117,247 - $133,599	-457 Reduced 33.85%	893 $248,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $340,794 - $414,072	1,350 New	1,350 $373,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $69,068 - $87,482	-248 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $2,935 - $3,838	10 Added 4.2%	248 $82,000
Q1 2018 Jun 25, 2018	BUY	$260.13 - $367.91 $61,910 - $87,562	238 New	238 $65,000

996

128M

1.28M

1.49M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.